Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01877941 · ClinicalTrials.gov registry record · NA

Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time

A NA study of Myocardial Infarction and Myocardial Ischemia, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
39
Enrollment target
2
Study locations

NCT01877941 is a NA study of Myocardial Infarction and Myocardial Ischemia that has completed, run by University of California, San Francisco. The registered enrollment target is 39 participants, below the 4,681-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01877941, a NA study of Myocardial Infarction and Myocardial Ischemia, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
39 participants
Enrollment target
2
Study locations

Study Summary

The specific aim of this study is to assess whether a device approved by the FDA to measure pulse oximetry can accurately estimate cardiac output.

Interventions

  • DEVICE Pulmonary Artery Catheter (PAC)
  • DEVICE Endotracheal Cardiac Output Monitor (ECOM)
  • DEVICE Estimated Continuous Cardiac Output (esCCO)

Study Locations (2)

California

  • San Francisco VA Medical Center - San Francisco

Pennsylvania

  • Drexel University - Philadelphia

Trial Details

FieldValue
Enrollment Target 39 participants
Start Date 2012-12
Est. Completion 2013-12
Phase NA

What the Registry Record Tells You About NCT01877941

The ClinicalTrials.gov registry entry for NCT01877941 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,681-participant average among 64 other Myocardial Infarction trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Myocardial Infarction appearing as the primary indexed condition, and to 3 interventions - of which Pulmonary Artery Catheter (PAC) is the first listed.

NCT01877941 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01877941 about?

NCT01877941 is a clinical study titled "Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time". The specific aim of this study is to assess whether a device approved by the FDA to measure pulse oximetry can accurately estimate cardiac output.

What is the current status of trial NCT01877941?

This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2012-12. Estimated completion is 2013-12.

What conditions does trial NCT01877941 study?

This clinical trial studies the following conditions: Myocardial Infarction, Myocardial Ischemia.

What interventions are being tested in trial NCT01877941?

The interventions under investigation include: Pulmonary Artery Catheter (PAC) (DEVICE), Endotracheal Cardiac Output Monitor (ECOM) (DEVICE), Estimated Continuous Cardiac Output (esCCO) (DEVICE).

Who is sponsoring clinical trial NCT01877941?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01877941 being conducted?

This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Myocardial Infarction

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.